Mark Mitchell
A riveting tale of how shady investors and crooked brokerages conspired to manipulate the shares of a small drug compnay with some innovative ideas about how to develop cancer drugs.
And a blueprint for how these bad actors do the same to other firms, . . and rip off ordinary investors, Unlike other books on finance, this reads like a thriller or a conspiracy yarnbut it's all true!,